Corrigendum to “Results from three phase 1 trials of NNC9204-1177, a glucagon/GLP-1 receptor co-agonist: effects on weight loss and safety in adults with overweight or obesity” [Mol Metab 78 (2023) 101801]
| Autor: | Friedrichsen, Martin Haljeta, Endahl, Lars, Kreiner, Frederik Flindt, Goldwater, Ronald, Kankam, Martin, Toubro, Søren, Nygård, Sune Boris |
|---|---|
| Zdroj: | In Molecular Metabolism November 2024 89 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|